Cambridge Investment Research Advisors, Inc. Cortexyme, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $36.4 Billion
  • Q3 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cortexyme, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,200 shares of CRTX stock, worth $19,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,200
Previous 15,200 -0.0%
Holding current value
$19,608
Previous $25,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
N/A
15,200 New
15,200 $25,000

Others Institutions Holding CRTX

# of Institutions
50
Shares Held
12.6M
Call Options Held
98.3K
Put Options Held
0
View Full List

About Cortexyme, Inc.

CRTX Quotes by TradingView
  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email